Internal Medicine, Nephrology · Farmington, NM
NPI
1720185788
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
812 W Maple St
Farmington, NM, 87401
Phone (505) 326-6521
Groups this clinician bills Medicare through
Medicare paid, 2024
$996K
18,973 services
Medicare patients, 2024
556
Average age 66
Drug cost, 2024
$262K
3,003 prescriptions
Company payments, 2025
$28.68
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Bevan was code 90970 (esrd related services (not dialysis)), 15,443 times for 312 patients. In total Mark Bevan billed 18,973 services in 34 codes, and Medicare paid $996K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90970 ESRD Related Services (not dialysis) | Office | 15,443 | 312 | $7.73 | $119K |
| 90960 ESRD Related Services (not dialysis) | Office | 2,220 | 344 | $292.90 | $650K |
| 90961 ESRD Related Services (not dialysis) | Office | 591 | 230 | $243.22 | $144K |
| 90966 ESRD Related Services (not dialysis) | Office | 200 | 31 | $243.25 | $49K |
| 99214 Office E&M - Established | Office | 51 | 36 | $69.75 | $3,557 |
| 99214 Office E&M - Established | Facility | 46 | 42 | $74.53 | $3,428 |
| 99215 Office E&M - Established | Office | 44 | 20 | $129.01 | $5,677 |
| 99232 Hospital E&M - Subsequent | Facility | 39 | 25 | $64.90 | $2,531 |
| 90962 ESRD Related Services (not dialysis) | Office | 37 | 25 | $163.09 | $6,034 |
| 90935 Hemodialysis | Facility | 33 | 23 | $58.10 | $1,917 |
| 99215 Office E&M - Established | Facility | 24 | 23 | $111.67 | $2,680 |
| 90937 Hemodialysis | Facility | 21 | 14 | $83.73 | $1,758 |
| 80053 Clinical Chemistry | Office | 19 | 16 | $10.35 | $197 |
| 99213 Office E&M - Established | Facility | 19 | 19 | $51.95 | $987 |
| 83735 Clinical Chemistry | Office | 19 | 17 | $6.57 | $125 |
By year: 2022 $1.2M for 14,010 services; 2023 $950K for 18,560 services; 2024 $996K for 18,973 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 19 | 16 | $10.35 | $197 |
| 83735 Clinical Chemistry | 19 | 17 | $6.57 | $125 |
| 85025 Blood Count | 19 | 16 | $7.61 | $145 |
| 84100 Clinical Chemistry | 18 | 17 | $4.65 | $83.7 |
| 81001 Clinical Chemistry | 12 | 11 | $3.11 | $37.32 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark Bevan prescribed most often to Medicare patients was Carvedilol, with 434 prescriptions and refills. In total Mark Bevan wrote 3,003 Medicare prescriptions that cost $262K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 434 | 488 | 108 | $2,989 |
| Losartan Potassium Generic | 328 | 392 | 90 | $2,629 |
| Calcium Acetate Generic | 281 | 320 | 76 | $19K |
| Sevelamer Carbonate Generic | 155 | 173 | 46 | $29K |
| Pantoprazole Sodium Generic | 152 | 210 | 36 | $2,778 |
| Atorvastatin Calcium Generic | 116 | 144 | 28 | $747 |
| Gabapentin Generic | 113 | 124 | 25 | $1,115 |
| Nifedipine Er Nifedipine | 111 | 121 | 24 | $1,679 |
| Cyclobenzaprine Hcl Generic | 108 | 108 | 44 | $827 |
| Trazodone Hcl Generic | 76 | 88 | 18 | $395 |
| Lokelma Sodium Zirconium Cyclosilicate | 55 | 63 | 22 | $59K |
| Omeprazole Generic | 54 | 70 | 14 | $576 |
| Loperamide Loperamide Hcl | 52 | 52 | 13 | $765 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 50 | 51 | 21 | $705 |
| Clopidogrel Clopidogrel Bisulfate | 48 | 66 | 11 | $412 |
Brand drugs: 339 claims; generic drugs: 2,597 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Bevan $28.68 ($28.68 in general payments such as food, travel and fees) from 1 company. The largest payer was Lilly USA, LLC with $28.68.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 1 | $28.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.